Overexpression of miR-329-3p sensitizes osteosarcoma cells to cisplatin through suppression of glucose metabolism by targeting LDHA.
This study demonstrates a miR-329-3p-LDHA-glucose metabolism-cisplatin resistance axis in osteosarcoma cells, providing a miRNAs-based therapeutic strategy against chemoresistant osteosarcoma. This article is protected by copyright. All rights reserved.
PMID: 33058436 [PubMed - as supplied by publisher]
Source: Cell Biology International - Category: Cytology Authors: Li G, Li Y, Wang DY Tags: Cell Biol Int Source Type: research
More News: Biology | Bone Cancers | Cancer & Oncology | Chemotherapy | Cytology | Osteosarcoma | Study | Toxicology